BlackRock Portfolio Management LLC 13D and 13G filings for Keros Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-17 11:33 am Purchase | 2026-06-30 | 13G | KEROS THERAPEUTICS INC KROS | BlackRock Portfolio Management LLC | 1,122,874 5.700% | 1,122,874 (New Position) | Filing |